Long-term survival after surgical intervention for bone disease in multiple myeloma

Annals of Oncology

Volumn 16, Issue 2, 2005, Pages 222-227

  Zeifang, Felix ^a   Zahlten Hinguranage, A ^a   Goldschmidt, H ^a   Cremer, F ^a   Bernd, L ^a   Sabo, D ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bone; Mortality; Multiple myeloma; Oncological surgery

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN;

ADULT; AGE; AGED; ARTICLE; BONE DISEASE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HUMAN; LONG BONE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; ORTHOPEDIC SURGERY; OSTEOLYSIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SPINE SURGERY; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME; WEIGHT BEARING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OSTEOLYSIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WEIGHT-BEARING;

EID: 14644445165     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdi054     Document Type: Article

References (30)

1. Lathinen R, Laakso M, Palva I et al. Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Lancet 1992; 340: 1049-1052.
2. Tatsui H, Onomura T, Morishita S et al. Survival rates of patients with metastatic spinal cancer after scintigraphic detection of abnormal radioactive accumulation. Spine 1996; 21: 2143-2148.
3. Wedin R, Bauer HC, Rutqvist LE. Surgical treatment for skeletal breast cancer metastases: a population-based study of 641 patients. Cancer 2001; 92: 257-262.
4. Alexanian R, Dimopoulos M. The treatment of multiple myeloma. N Engl J Med 1994; 330: 484-489.
5. Child JA, Morgan GJ, Davies FE et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875-1883.
6. Kivioja AH, Karaharju EO, Elomaa I, Bowling TO. Surgical treatment of myeloma of bone. Eur J Cancer 1992; 28A: 1865-1869.
7. Papagelopoulos PJ, Galanis EC, Greipp PR, Sim FH. Prosthetic hip replacement for pathologic or impending pathologic fractures in myeloma. Clin Orthop 1997; 341: 192-205.
8. Dürr HR, Wegener B, Krodel A et al. Multiple myeloma: surgery of the spine: retrospective analysis of 27 patients. Spine 2002; 27: 320-324.
9. Oken MM, Creech RH, Tormey DC et al. Toxicity response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
10. Durie BM Salmon SE. A clinical staging system for multiple myeloma. Cancer 1975; 36: 842-854.
11. Bataille R, Boccadoro M, Klein B et al. C-reactive protein and serum β2-Microglobulin produce a simple and powerful myeloma staging system. Blood 1992; 80: 733-737.
12. Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop 1989; 249: 256-264.
13. Frankel HL, Hancock DO, Hyslop G et al. The value of postural reduction in the initial management of closed injuries to the spine with paraplegia and tetraplegia. Paraplegia 1969; 7: 182.
14. Ruggieri P, De Cristofaro R, Picci P et al. Complications and surgical indications in 144 cases of nonmetastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy. Clin Orthop 1993; 295: 226-238.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
16. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972; 34: 187-220.
17. Harris RJ. A Primer of Multivariate Statistics, 2nd edition. New York: Academic Press 1985.
18. Sundaresan N, Steinberger AA, Moore F et al. Indications and results of combined anterior-posterior approaches for spine tumour surgery. J Neurosurg 1996; 85: 438-446.
19. Harrington KD. Anterior decompression and stabilisation of the spine as a treatment for vertebral collapse and spinal cord compression from metastatic malignancy. Clin Orthop 1988; 233: 177-197.
20. Hosono N, Yonenobu K, Fuji T et al. Orthopaedic management of spinal metastases. Clin Orthop 1995; 312: 148-159.
21. Nather A, Bose K. The results of decompression of cord or cauda equina compression from metastatic extradural tumors. Clin Orthop 1982; 169: 103-108.
22. Lee CK, Rosa R, Fernand R. Surgical treatment of tumors of the spine. Spine 1986; 11: 201-208.
23. Rompe JD, Eysel P, Hopf C, Heine J. Metastatic spinal cord compression - options for surgical treatment. Acta Neurochir 1993; 123: 135-140.
24. Kluger P, Korge A, Scharf HP. Strategy for the treatment of patients with spinal neoplasms. Spinal Cord 1997; 35: 429-436.
25. Helweg-Larsen S. Clinical outcome in metastatic spinal cord compression. A prospective study of 153 patients. Acta Neurol Scand 1996; 94: 269-275.
26. Pascal-Moussellard H, Broc G, Pointillart V et al. Complications of vertebral metastasis surgery. Eur Spine J 1998; 7: 438-444.
27. Levine SA, Perin LA, Hayes D, Hayer WS. An evidence-based evaluation of percutaneous vertebroplasty. Manag Care 2000; 9: 56-60.
28. Alexandrakis MG, Passam FH. Ki-67 Proliferation Index. Correlation with prognostic parameters and outcome in multiple myeloma. J Clin Oncol 2004; 27: 8-13.
29. Hannisdal E, Kildahl-Andersen O, Grottum KA, Lamvik J. Prognostic factors in multiple myeloma in a population-based trial. Eur J Haema- tol 1990; 45: 198-202.
30. Tsuchiya J, Murakami H, Kanoh T. Ten year survival and prognostic factors in multiple myeloma. Br J Haematol 1994; 97: 832-834.